Immunohistochemical staining for GZMB, the key CD8 + T-cell effector molecule, revealed that IAC tumors had lower GZMB level, indicating the attenuated activity of CD8 + T cells in IAC tumours (Fig. 4C). This evidence concerns the gene GZMB and neoplasm.